Description:

CALGB: 80203 Follow-up and Response Form NCT00077233 Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B4C3AFD5-EA93-071F-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B4C3AFD5-EA93-071F-E034-0003BA12F5E7

Keywords:
Versions (4) ▾
  1. 8/27/12
  2. 1/8/15
  3. 1/9/15
  4. 7/5/15
Uploaded on:

July 5, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

CALGB: 80203 Follow-up and Response Form NCT00077233

No Instruction available.

  1. StudyEvent: CALGB: 80203 Follow-up and Response Form
    1. No Instruction available.
Header
Are data amended?
Patient demographics
Miscellaneous Patient Assessment
Patients vital status
Cause of death
Site(s) of progression
Is the patient receiving any non-protocol cancer therapy not previously reported?
Has a new primary cancer or AML/MDS been diagnosed that has not been previously reported?
Ccrr Module For Calgb: 80203 Follow-up And Response Form

Similar models